Analysis of the Western European Immunochemistry Market

Integrated Systems with Ultrasensitive Immunoassay Platform Drive Growth

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

Acquisitions and partnerships have been the talk of the market. This study analyses how the immunochemistry market will change in light of increasing demand for integrated immunochemistry analysers and assays as consolidation occurs across Western Europe. The research includes a market overview, market engineering measurements, revenue forecasts, company profiling, and key trends for the immunochemistry market and its segments: immunoassay, clinical chemistry, and integrated analysers. Regional analyses are segmented by the United Kingdom, Germany, France, Italy, Spain, Benelux, and Scandinavia. The study period is 2011–2021 with a base year of 2014.

Table of Contents

Executive SummaryKey FindingsScope and SegmentationKey Questions This Study Will AnswerMarket Engineering MeasurementsCEO’s PerspectiveKey Companies to WatchRecent Market Developments3 Big PredictionsMarket OverviewMarket Segmentation Market Segmentation (continued)Immunochemistry Market—Common TestsImmunochemistry Market—Common Tests (continued)Defining Healthcare Trends in the FutureCompetitive PlaybookNew Market OpportunitiesNew Market Opportunities (continued)New Market Opportunities (continued)Merger, Acquisition, and Partnership AssessmentMerger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Merger, Acquisition, and Partnership Assessment (continued)Drivers, Restraints, and Trends—Total Immunochemistry MarketMarket DriversMarket RestraintsImpact Mapping of Drivers and RestraintsMarket Growth Opportunity AnalysisForecast and Trends—Total Immunochemistry MarketMarket Engineering MeasurementsForecast Assumptions and DefinitionsRevenue ForecastInstruments vs. Reagents Revenue ForecastRevenue Forecast DiscussionPercent Revenue Forecast by RegionRevenue Forecast by RegionKey Market TrendsPricing AnalysisSegment Lifecycle AnalysisCompetitive EnvironmentMarket ShareMarket Share AnalysisImmunoassay Segment AnalysisMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionMetrics AnalysisMarket ShareMarket Share AnalysisCompetitive StructureClinical Chemistry Segment AnalysisMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionMetrics AnalysisMarket ShareMarket Share AnalysisCompetitive StructureIntegrated Analysers Segment AnalysisMarket Engineering MeasurementsRevenue ForecastRevenue Forecast DiscussionMetrics AnalysisMarket ShareMarket Share AnalysisCompetitive StructureThe United Kingdom AnalysisRevenue ForecastRevenue Forecast DiscussionGermany AnalysisRevenue ForecastRevenue Forecast DiscussionFrance AnalysisRevenue ForecastRevenue Forecast DiscussionItaly AnalysisRevenue ForecastRevenue Forecast DiscussionSpain AnalysisRevenue ForecastRevenue Forecast DiscussionBenelux AnalysisRevenue ForecastRevenue Forecast DiscussionScandinavia AnalysisRevenue ForecastRevenue Forecast DiscussionKey Company ProfilesRoche DiagnosticsRoche Diagnostics (continued)Siemens Healthcare DiagnosticsSiemens Healthcare Diagnostics (continued)Siemens Healthcare Diagnostics (continued)Abbott DiagnosticsAbbott Diagnostics (continued)Ortho Clinical DiagnosticsOrtho Clinical Diagnostics (continued)Thermo Fisher ScientificThermo Fisher Scientific (continued)Beckman Coulter (Danaher Group)Beckman Coulter (Danaher Group)The Last WordThe Last Word—3 Big PredictionsThe Last Word—DiscussionThe Last Word—Discussion (continued)The Last Word—Discussion (continued)Legal DisclaimerAppendixDrivers ExplainedDrivers Explained (continued)Drivers Explained (continued)Restraints ExplainedRestraints Explained (continued)Restraints Explained (continued)Total Healthcare ExpenditureTotal Healthcare Expenditure (continued)Public Healthcare ExpenditurePublic Healthcare Expenditure (continued)Private Healthcare Expenditure Private Healthcare Expenditure (continued)Number of Hospital BedsNumber of Hospital Beds (continued)Number of HospitalsNumber of Hospitals (continued)Additional Sources of Information on DiabetesList of Companies in “Others” List of Companies in “Others” (continued) List of Companies in “Others” (continued) List of Companies in “Others” (continued) Market Engineering MethodologyList of ExhibitsList of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)List of Exhibits (continued)

Infographic





Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.